These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9532159)

  • 1. Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts.
    Elmer DS; Abdulkarim AB; Fraga D; Shokouh-Amiri H; Stratta RJ; Hathaway DK; Reddy K; Gaber AO
    Transplant Proc; 1998 Mar; 30(2):523-4. PubMed ID: 9532159
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.
    Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Pellar S; Josephson MA; Thistlethwaite JR
    Transplant Proc; 1998 Mar; 30(2):507-8. PubMed ID: 9532150
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil/tacrolimus/single-shot versus azathioprine/cyclosporine/ATG in pancreas-kidney transplantation: results of a prospective randomized single-center study.
    Büsing M; Martin D; Schulz T; Heimes M; Klempnauer J; Kozuschek W
    Transplant Proc; 1998 Mar; 30(2):516-7. PubMed ID: 9532155
    [No Abstract]   [Full Text] [Related]  

  • 4. Tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
    Peddi VR; Demmy AM; Munda R; Alexander JW; First MR
    Transplant Proc; 1998 Mar; 30(2):509-11. PubMed ID: 9532151
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycophenolate mofetil and tacrolimus for induction and maintenance therapy after pancreas transplantation.
    Gruessner RW; Sutherland DE; Drangstveit MB; West M; Gruessner AC
    Transplant Proc; 1998 Mar; 30(2):518-20. PubMed ID: 9532156
    [No Abstract]   [Full Text] [Related]  

  • 6. First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation.
    Kahl A; Bechstein WO; Platz K; Müller A; Berweck S; Venz S; Neuhaus P; Frei U
    Transplant Proc; 1998 Mar; 30(2):505-6. PubMed ID: 9532149
    [No Abstract]   [Full Text] [Related]  

  • 7. Pancreas transplantation without antibody therapy.
    Corry RJ; Shapiro R; Egidi MF; Jordan ML; Scantlebury V; Vivas C; Gritsch HA; Starzl TE
    Transplant Proc; 1998 Mar; 30(2):299-300. PubMed ID: 9532050
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary experience with FK 506 in pancreas transplant recipients.
    Stratta RJ; Taylor RJ; Castaldo P; Sindhi R; Sudan D; Frisbie K; Cushing K
    Transplant Proc; 1995 Dec; 27(6):3024. PubMed ID: 8539823
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholesterol control: long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression.
    Burke GW; Ciancio G; Alejandro R; Roth D; Ricordi C; Skyler JS; Tzakis A; Miller J
    Transplant Proc; 1998 Mar; 30(2):513-4. PubMed ID: 9532153
    [No Abstract]   [Full Text] [Related]  

  • 11. Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity.
    Hariharan S; Munda R; Cavallo T; Demmy AM; Schroeder TJ; Alexander JW; First MR
    Transplantation; 1996 Apr; 61(8):1161-5. PubMed ID: 8610411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
    Gruessner RW; Burke GW; Stratta R; Sollinger H; Benedetti E; Marsh C; Stock P; Boudreaux JP; Martin M; Drangstveit MB; Sutherland DE; Gruessner A
    Transplantation; 1996 Jan; 61(2):261-73. PubMed ID: 8600635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A.
    Kanzler S; Lohse AW; Schirmacher P; Hermann E; Otto G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1996 Feb; 34(2):128-31. PubMed ID: 8659188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved solitary pancreas transplant graft survival in the modern immunosuppressive era.
    Odorico JS; Becker YT; Groshek M; Werwinski C; Becker BN; Pirsch JD; Sollinger HW
    Cell Transplant; 2000; 9(6):919-27. PubMed ID: 11202579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
    Stegall MD; Wachs ME; Everson G; Steinberg T; Bilir B; Shrestha R; Karrer F; Kam I
    Transplantation; 1997 Dec; 64(12):1755-60. PubMed ID: 9422416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to noninduction therapy with enteric drainage.
    Kaufman DB; Leventhal JR; Koffron A; Gheorghiade M; Elliott MD; Parker MA; Abecassis MM; Fryer JP; Stuart FP
    Surgery; 2000 Oct; 128(4):726-37. PubMed ID: 11015108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients.
    Corry RJ; Egidi MF; Shapiro R; Sugitani A; Gritsch HA; Jordan ML; Dodson SF; Vivas CA; Scantlebury VP; Rao AS; Fung JJ; Starzl TE
    Transplant Proc; 1998 Mar; 30(2):521. PubMed ID: 9532157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.
    Bechstein WO; Malaise J; Saudek F; Land W; Fernandez-Cruz L; Margreiter R; Nakache R; Secchi A; Vanrenterghem Y; Tydén G; Van Ophem D; Berney T; Boucek P; Landgraf R; Kahl A; Squifflet JP;
    Transplantation; 2004 Apr; 77(8):1221-8. PubMed ID: 15114089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression.
    Jordan ML; Shapiro R; Vivas CA; Scantlebury VP; Darras FS; Carrieri G; McCauley J; Demetris AJ; Randhawa P; Jensen C
    Transplant Proc; 1993 Feb; 25(1 Pt 1):638-40. PubMed ID: 7679827
    [No Abstract]   [Full Text] [Related]  

  • 20. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation.
    Drachenberg CB; Klassen DK; Weir MR; Wiland A; Fink JC; Bartlett ST; Cangro CB; Blahut S; Papadimitriou JC
    Transplantation; 1999 Aug; 68(3):396-402. PubMed ID: 10459544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.